Bibliography, Dengue Fever
Future Development of Dengue Vaccines
Halstead, S.B and Deen,J.(2002) “The future of dengue vaccines” Rapid Review. The Lancet; Oct 19, 2002; 360, 9341; ProQuest Health & Medical Complete; pg. 1243. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11276-1/fulltext [Accessed 10 September 2013]
The Lancet is a world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. This qualitative study identifies the opinions of researchers about the dengue vaccine, supported with various facts on the development of the disease dengue fever, one of the mosquito-borne diseases and identifies other research methods being done by organizations such as the, World Health Organization (WHO). This journal has additionally informs experts on the specific field on the newest and most detailed information regarding the development of dengue vaccine and the genetics information the virus contains, supported with researchers opinion regarding the development which also contains the threat it poses if left untreated. The conclusions were that there are still unanswered questions regarding whether or not an effective and safe vaccine for the disease, dengue fever. The current development in vaccine is already funded, though limited, due to four different types of serotypes a virus may contain; a vaccine has to work against all four serotypes. Both authors, Scott B Halstead and Jacqueline Deen, is both equipped with the necessary knowledge to write a perfectly reliable text such as this journal as they are both conducting their own practice regarding the mosquito-borne disease, dengue fever. The paper provides detailed scientific facts in organized forms, obtained by the Department of Preventive Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, and Pediatric Dengue Vaccine Initative, International Vaccine Institute. The article provides a well-informed textual information which
Halstead, S.B and Deen,J.(2002) “The future of dengue vaccines” Rapid Review. The Lancet; Oct 19, 2002; 360, 9341; ProQuest Health & Medical Complete; pg. 1243. Available from: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(02)11276-1/fulltext [Accessed 10 September 2013]
The Lancet is a world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. This qualitative study identifies the opinions of researchers about the dengue vaccine, supported with various facts on the development of the disease dengue fever, one of the mosquito-borne diseases and identifies other research methods being done by organizations such as the, World Health Organization (WHO). This journal has additionally informs experts on the specific field on the newest and most detailed information regarding the development of dengue vaccine and the genetics information the virus contains, supported with researchers opinion regarding the development which also contains the threat it poses if left untreated. The conclusions were that there are still unanswered questions regarding whether or not an effective and safe vaccine for the disease, dengue fever. The current development in vaccine is already funded, though limited, due to four different types of serotypes a virus may contain; a vaccine has to work against all four serotypes. Both authors, Scott B Halstead and Jacqueline Deen, is both equipped with the necessary knowledge to write a perfectly reliable text such as this journal as they are both conducting their own practice regarding the mosquito-borne disease, dengue fever. The paper provides detailed scientific facts in organized forms, obtained by the Department of Preventive Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, and Pediatric Dengue Vaccine Initative, International Vaccine Institute. The article provides a well-informed textual information which